Table 1

Growth inhibitory activities (GI50)(μg/ml) of various anti-cancer agents against 10 human lung cancer cell lines – Set 1

Drug

PC7

PC9

PC14

A549

Lu65

LK-2

H69

N231

Lu135

SBC-3


CDDP

4.55

3.53

2.86

5.46

3.39

4.72

1.64

1.25

0.22

4.84

SN38

5.05

3.45

3.79

6.80

0.48

4.25

0.77

0.66

0.05

0.07

VIN

2.64

1.43

>10

>10

0.06

0.02

0.02

0.01

0.02

0.51

DOC

2.46

21.34

20.38

21.31

3.61

26.31

4.72

6.04

0.53

>50

GEM

<0.05

14.28

>500

>500

79.53

54.61

3.73

3.88

<0.05

<0.05

5FU

2.76

5.84

>10

>10

8.76

>10

>10

>10

5.68

0.51

CBDCA

95

70

>100

46.3

71

0.225

7.54

45

61

3.5

PAC

6.7

39

34

51

34

20

<0.001

7

5.5

0.5


Gemma et al. BMC Cancer 2006 6:174   doi:10.1186/1471-2407-6-174

Open Data